Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02137434
Other study ID # Acute calcium
Secondary ID
Status Recruiting
Phase N/A
First received May 9, 2014
Last updated May 9, 2014
Start date February 2014
Est. completion date December 2015

Study information

Verified date May 2014
Source Rio de Janeiro State University
Contact Thaís S Ferreira, MSc.
Phone 55 21 2334-2063
Email thaissferreira@gmail.com
Is FDA regulated No
Health authority Brazil: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of the study is to investigate calcium acute influence over the postprandial effects of a fatty meal on serum calcium, plasma glucose and triglycerides, blood pressure, oxidative stress, and endothelial function in obese women.


Description:

Studies suggest that dietary calcium intake is inversely associated with cardiovascular disease, but supplementary calcium appears to be associated with raised risk of cardiovascular events. Fatty meals lead to oxidative and inflammation which seems to interfere in postprandial dismetabolism, a predictor of cardiovascular events. To investigate calcium acute influence over the postprandial effects of a fatty meal a crossover, controlled, and randomized clinical trial will be conducted with obese adult women who will be randomized into one of the three interventions, characterized by a fatty meal with different contents of calcium: low calcium (40 mg), high dietary calcium (540 mg from non-fat milk), and high supplementary calcium (540 mg from calcium carbonate). Each participant will receive all three meals and one of them every week. Before meals' intake blood sample will be collected and endothelial function assess will be performed. Participants will eat the specific meal and endothelial function will be assessed again after 120 minutes. Blood sample collections will be repeated every 60 minutes after meal's intake to perform latter biochemical analyzes to determine: 8-isoprostane levels, to assess oxidative stress status; triglycerides; glucose; insulin; and serum calcium. Blood pressure will be continuously assessed during 25 minutes before meals' intake and during 2 hours after it.


Recruitment information / eligibility

Status Recruiting
Enrollment 15
Est. completion date December 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender Female
Age group 25 Years to 50 Years
Eligibility Inclusion Criteria:

- body mass index (BMI) greater than or equal to 30 kg/m2 and below 40 kg/m2

- habitual dietary calcium intake below 500 mg per day

Exclusion Criteria:

- smoking

- dietary supplements or drugs that could interfere with body weight, metabolic profile and blood pressure

- diabetes

- thyroid dysfunction

- hypertension

- angina pectoris

- heart kidney or liver failure

- intestinal malabsorption

- acute or chronic inflammation

- HIV infection

- autoimmune diseases

- cancer

- chronic obstructive pulmonary disease

- dyslipidemia with indication for drug treatment

- history of myocardial infarction or stroke

- pregnancy and lactation

- menopause

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject)


Related Conditions & MeSH terms


Intervention

Other:
Dietary calcium
Dietary calcium from skimmed milk
Dietary Supplement:
Supplementary calcium
Supplementary calcium from calcium carbonate

Locations

Country Name City State
Brazil Discipline of Clinical and Experimental Pathophysiology, Rio de Janeiro State University Rio de Janeiro

Sponsors (2)

Lead Sponsor Collaborator
Rio de Janeiro State University Rio de Janeiro State Research Supporting Foundation (FAPERJ)

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Other Plasma triglycerides Plasma triglycerides will be assessed by automated techniques Plasma triglycerides will be assessed in the fasting period and each hour during three hours after meals' intake No
Other Plasma glucose Plasma glucose will be assessed by glucose oxidase method. Plasma glucose will be assessed in the fasting period and each hour during three hours after meals' intake No
Other Oxidative stress Oxidative stress will be assessed by evaluating serum levels of 8-isoprostane and malondialdehyde by ELISA method. Oxidative stress will be assessed in the fasting period and each hour during three hours after meals' intake No
Primary Blood pressure Blood pressure will be assessed by digital photoplethysmography. Blood pressure will be assessed continuously 25 min before meals' intake and 2 hours after it. No
Secondary Endothelial function Endothelial function will be assessed by laser doppler fluxometry. Endothelial function will be assessed after meals' intake and 2 hours after it. No
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2